
PatenSee
Clinical-stage medical device company developing a contactless, optical imaging system for rapid vascular access monitoring in dialysis patients.
About
PatenSee is a clinical-stage medical device company focused on improving the care of hemodialysis patients. They are developing a contactless, optical imaging system that, combined with AI, digitizes and standardizes the physical examination of vascular access sites to enable early prediction of stenosis.
Similar companies
AI-powered diagnostic system for predictive analytics in healthcare.
Shares Healthcare, HealthTech
Reinventing pregnancy care with remote monitoring and management technology for providers and expectant mothers.
Shares Healthcare, HealthTech
Develops AI-powered decision support tools for personalized medical data interpretation and prediction.
Shares Healthcare, Detection
Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.
Shares Healthcare, Biotech
Liger Medical develops breakthrough optical diagnostic devices and software for early cancer detection and other medical purposes.
Shares Healthcare, Clinical
Transforming healthcare by turning scientific fiction into scientific facts.
Shares Healthcare, HealthTech
Key facts
- Website
- patensee.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2019
- Employees
- 5
- Business model
- B2B
Tech stack
Detected on patensee.com, last scanned 15 Oct 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Frequently asked
Is PatenSee trustworthy and reputable?
StartupHub's Data Trust & Reputation score for PatenSee is 70 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does PatenSee have?
PatenSee has approximately 5 people on record.